Clinical Trial Update: Therapeutics for Moderate and Severe Dengue [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for therapeutics targeting moderate and severe dengue indicates the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue

Snippet

Sponsor: Oxford University Clinical Research Unit, Vietnam | Conditions: Dengue, Severe Dengue | Phase 3 | Status: NOT_YET_RECRUITING